FDA adds warning for intestinal blockage on Novo's Ozempic

FDA adds warning for intestinal blockage on Novo's Ozempic

4.5
(160)
Write Review
More
$ 18.00
Add to Cart
In stock
Description

While GLP-1 drugs from Novo Nordisk and Eli Lilly are believed to be relatively free of serious side effects, a few problems have emerged as the treatments have gained wider and longer-term use.

Woman sues drug makers of Ozempic and Mounjaro over severe gastrointestinal issues

FDA updates Novo Nordisk's Ozempic drug label with side effect alert — MedWatch

FDA Adds Intestinal Blockage as Potential Side Effect to Ozempic, Wegovy - Advanced Laparoscopic Surgeons

FDA Adds Warning To Ozempic Label About Ileus, Intestinal Blockage

FDA Adds Intestinal Blockage Reports to Ozempic Labeling

FDA reports no link between weight-loss drugs and suicidal thoughts - The Washington Post

Ozempic Stomach Paralysis Lawsuits

Counterfeit' Ozempic Is Under Investigation As at Least 3 Users Are Hospitalized

Ozempic Stomach Paralysis Lawsuit Update

Wegovy class has higher GI side effect risk than older weight loss drug in study

TGA investigating potential link between diabetes drug Ozempic and reports of gastro-intestinal side effects, Health

FDA Acknowledges Blocked Intestines Ozempic Side Effect - NewBeauty

Ozempic side effects cited in lawsuit not surprising, pharmacists say

Reports Say Ozempic May Lead to Blocked Intestines

Ozempic and Wegovy Manufacturers Accused of Downplaying the Drugs' Risks